AI assistant
INSMED Inc — Director's Dealing 2025
Jun 3, 2025
30150_dirs_2025-06-03_0e283b86-308c-4cde-9248-b4d068b53ce3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-05-30
Reporting Person: Smith Michael Alexander (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-30 | Common Stock | S | 6327 | $68.56 | Disposed | 91045 | Direct |
| 2025-05-30 | Common Stock | S | 20000 | $70 | Disposed | 71045 | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 6,327 shares sold at prices ranging from $68.13 to $68.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $70.00 to $70.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.